CTD regulations will be obligatory to new drug application, KFDA says

Published: 2009-03-26 06:58:00

Updated: 2009-03-26 06:58:00

The Korea Food and Drug Administration says the common technical document (CTD) related regulations will be compulsorily applicable to new drug application from this March, but its full implementation to other medicines will be flexible depending on the industry’s general environments.

An appl...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK